LeaderMed is a global, innovative biopharmaceutical company that leverages the Asia-Pacific market, expediting R&D cost-effectively;

In addition to penetrating the APAC market and bringing significant sales, we generate quality clinical data that can be used by partners to initiate Phase 3 or pivotal trials elsewhere, such as the U.S. and EMEA;

LeaderMed is developing first-in-class therapeutics in several diseases with significant unmet needs. The current company pipeline includes therapeutic candidates for: diabetes, obesity, hemophilia A and B, lung fibrosis, myocardial fibrosis, and scar-less wound healing.

Headquartered in the U.S. and with operations and manufacturing capabilities in Korea, Singapore and China, LeaderMed is led by a veteran executive team featuring decades of collective expertise in the full lifecycle of drug development.

Biotechnology

Clinical Trials

Therapeutics

Leadermed Health Group Limited

Leadermed Health Group Limited's headquarters in New York City, United States

Leadermed Health Group Limited

Org chart

Teams

Offices

Similar companies